CY1123687T1 - Ενωσεις 4-υποκατεστημενου βενζοξαβορολιου και χρησεις αυτων - Google Patents

Ενωσεις 4-υποκατεστημενου βενζοξαβορολιου και χρησεις αυτων

Info

Publication number
CY1123687T1
CY1123687T1 CY20201100978T CY201100978T CY1123687T1 CY 1123687 T1 CY1123687 T1 CY 1123687T1 CY 20201100978 T CY20201100978 T CY 20201100978T CY 201100978 T CY201100978 T CY 201100978T CY 1123687 T1 CY1123687 T1 CY 1123687T1
Authority
CY
Cyprus
Prior art keywords
substituted
compounds
ch2ch2ch3
ch2ch3
benzoxaborol compounds
Prior art date
Application number
CY20201100978T
Other languages
Greek (el)
English (en)
Inventor
Carlos Alemparte-Gallardo
M.R.K. ALLEY (Dickon)
David Barros-Aguirre
Ilaria Giordano
Vincent Hernandez
Xianfeng Li
Jacob J. Plattner
Original Assignee
Glaxosmithkline Intellectual Property (No. 2) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55409879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123687(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Intellectual Property (No. 2) Limited filed Critical Glaxosmithkline Intellectual Property (No. 2) Limited
Publication of CY1123687T1 publication Critical patent/CY1123687T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20201100978T 2015-02-12 2020-10-15 Ενωσεις 4-υποκατεστημενου βενζοξαβορολιου και χρησεις αυτων CY1123687T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15382055 2015-02-12
EP15382056 2015-02-12
EP15382054 2015-02-12
PCT/IB2016/050775 WO2016128948A1 (en) 2015-02-12 2016-02-12 4 -substituted benzoxaborole compounds and uses thereof

Publications (1)

Publication Number Publication Date
CY1123687T1 true CY1123687T1 (el) 2022-03-24

Family

ID=55409879

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100978T CY1123687T1 (el) 2015-02-12 2020-10-15 Ενωσεις 4-υποκατεστημενου βενζοξαβορολιου και χρησεις αυτων

Country Status (36)

Country Link
US (3) US20180037595A1 (enExample)
EP (2) EP3256480A1 (enExample)
JP (2) JP2018506540A (enExample)
KR (2) KR20170117158A (enExample)
CN (2) CN107548398A (enExample)
AU (3) AU2016217508A1 (enExample)
BR (2) BR112017017211B1 (enExample)
CA (2) CA2976030C (enExample)
CL (2) CL2017002060A1 (enExample)
CO (2) CO2017008816A2 (enExample)
CR (2) CR20170371A (enExample)
CY (1) CY1123687T1 (enExample)
DK (1) DK3256479T3 (enExample)
DO (2) DOP2017000189A (enExample)
EA (2) EA036516B1 (enExample)
ES (1) ES2821951T3 (enExample)
HR (1) HRP20201597T1 (enExample)
HU (1) HUE051113T2 (enExample)
IL (2) IL253864B (enExample)
LT (1) LT3256479T (enExample)
MA (2) MA41495A (enExample)
MX (2) MX379057B (enExample)
MY (1) MY194004A (enExample)
NZ (1) NZ734379A (enExample)
PE (2) PE20171432A1 (enExample)
PH (2) PH12017501427A1 (enExample)
PL (1) PL3256479T3 (enExample)
PT (1) PT3256479T (enExample)
RS (1) RS60885B1 (enExample)
SG (2) SG11201706511TA (enExample)
SI (1) SI3256479T1 (enExample)
SM (1) SMT202000565T1 (enExample)
TW (2) TWI730953B (enExample)
UA (1) UA120527C2 (enExample)
WO (2) WO2016128949A1 (enExample)
ZA (1) ZA201705456B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
DK3621609T3 (da) 2017-05-08 2022-08-29 Glaxosmithkline Ip Dev Ltd Sanfetrinem eller et salt eller ester deraf til anvendelse i behandling af mykobakterieinfektion
MX2020005464A (es) 2017-11-30 2020-12-03 Boragen Inc Compuestos de benzoxaborol y formulaciones de los mismos.
EP3836938A4 (en) 2018-08-18 2022-05-11 Boragen, Inc. SOLID FORMS OF SUBSTITUTED BENZOXAZOLE AND COMPOSITIONS THEREOF
CN110441344B (zh) * 2019-06-25 2020-09-29 北京大学 一种基于固体核磁共振技术检测rna结构的方法
CA3239097A1 (en) 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
JP2025520237A (ja) * 2022-06-23 2025-07-03 ミクウルク ファーマシューティカルズ, インコーポレイテッド ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
KR20240150582A (ko) 2023-04-08 2024-10-15 김태서 맥세이프 배터리팩을 포함한 아이폰 케이스

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
WO1998024753A1 (en) 1996-12-02 1998-06-11 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
ES2872962T3 (es) 2005-02-16 2021-11-03 Anacor Pharmaceuticals Inc Boronoftalidas para uso terapéutico
JP5084717B2 (ja) 2005-03-08 2012-11-28 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ キラル・ビスオキサゾリン触媒
TWM325238U (en) * 2006-12-29 2008-01-11 Universal Scient Ind Co Ltd Voltage regulator and voltage regulating system
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
SG172040A1 (en) 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
AU2011237681B2 (en) * 2010-04-07 2015-01-22 Glaxosmithkline Llc Process for preparing benzoxaboroles
DK2613788T3 (en) 2010-09-07 2017-08-07 Anacor Pharmaceuticals Inc BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
US8530452B2 (en) 2011-12-22 2013-09-10 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
CN102739587B (zh) 2012-06-16 2014-05-21 天地融科技股份有限公司 音频数据传输方法
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof

Also Published As

Publication number Publication date
HRP20201597T1 (hr) 2020-12-25
CN107531730B (zh) 2020-08-07
EA201791667A1 (ru) 2018-02-28
HUE051113T2 (hu) 2021-01-28
US10774096B2 (en) 2020-09-15
NZ734379A (en) 2023-06-30
MY194004A (en) 2022-11-07
WO2016128948A1 (en) 2016-08-18
LT3256479T (lt) 2020-12-28
KR20170117156A (ko) 2017-10-20
SG11201706511TA (en) 2017-09-28
SMT202000565T1 (it) 2020-11-10
TW201702250A (zh) 2017-01-16
CO2017008809A2 (es) 2017-11-10
PH12017501428A1 (en) 2018-01-15
CA2976308A1 (en) 2016-08-18
CO2017008816A2 (es) 2017-11-10
BR112017017211A2 (pt) 2018-04-03
JP2018506538A (ja) 2018-03-08
JP6771472B2 (ja) 2020-10-21
DOP2017000189A (es) 2018-02-15
MX2017010414A (es) 2018-05-11
IL253865A0 (en) 2017-10-31
KR20170117158A (ko) 2017-10-20
US11214582B2 (en) 2022-01-04
JP2018506540A (ja) 2018-03-08
TW201643173A (zh) 2016-12-16
PH12017501427A1 (en) 2018-01-15
MX379057B (es) 2025-03-10
US20180037595A1 (en) 2018-02-08
PT3256479T (pt) 2020-10-22
SI3256479T1 (sl) 2020-11-30
BR112017017211B1 (pt) 2023-04-25
MA41495A (fr) 2017-12-19
CA2976030C (en) 2023-09-26
PL3256479T3 (pl) 2021-06-14
EP3256480A1 (en) 2017-12-20
AU2016217508A1 (en) 2017-09-28
AU2020256369A1 (en) 2020-11-12
IL253864B (en) 2021-07-29
MX2017010413A (es) 2018-05-11
UA120527C2 (uk) 2019-12-26
AU2016217507B2 (en) 2019-03-14
EA201791671A1 (ru) 2018-02-28
WO2016128949A1 (en) 2016-08-18
CA2976030A1 (en) 2016-08-18
EP3256479A1 (en) 2017-12-20
TWI730953B (zh) 2021-06-21
MA41494B1 (fr) 2020-10-28
DK3256479T3 (da) 2020-11-02
MA41494A (fr) 2017-12-19
EP3256479B1 (en) 2020-07-29
US20210053996A1 (en) 2021-02-25
ZA201705456B (en) 2019-10-30
SG11201706510YA (en) 2017-09-28
BR112017017213A2 (pt) 2018-04-03
CR20170371A (es) 2018-01-22
IL253864A0 (en) 2017-09-28
RS60885B1 (sr) 2020-11-30
PE20171348A1 (es) 2017-09-13
DOP2017000188A (es) 2017-09-15
US20180044353A1 (en) 2018-02-15
PE20171432A1 (es) 2017-09-26
AU2016217507A1 (en) 2017-09-28
CN107531730A (zh) 2018-01-02
CR20170372A (es) 2017-10-19
CN107548398A (zh) 2018-01-05
ES2821951T3 (es) 2021-04-28
EA036516B1 (ru) 2020-11-18
CL2017002060A1 (es) 2018-03-16
CL2017002059A1 (es) 2018-03-16

Similar Documents

Publication Publication Date Title
CY1124404T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 και μεθοδοι χρησης αυτων
CY1124239T1 (el) Ενωσεις αμινο-τριαζολοπυριδινης και χρηση αυτων στην αγωγη του καρκινου
CY1125030T1 (el) Ενωσεις τρικυκλικης βενζοξαβορολης και χρησεις αυτων
CY1123025T1 (el) Αναστολεις βρωμοεπικρατειας
CY1123994T1 (el) Δικυκλικες-συντηγμενες ενωσεις ετεροαρυλιου ή αρυλιου ως ρυθμιστες της irak4
CY1120104T1 (el) Αναστολεις της syk
CY1121694T1 (el) Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4
PH12017501428A1 (en) 4-substituted benzoxaborole compounds and uses thereof
CY1123627T1 (el) Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
CY1126109T1 (el) Αναστολεις toy trpc6
CY1125169T1 (el) ΕΝΩΣΕΙΣ ΑΜΙΝΟΠΥΡΑΖΙΝΟ ΔΙΟΛΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΡΙ3Κ-γ
CY1123349T1 (el) Ενωσεις 6-ετεροκυκλυλ-4-μορφολιν-4-υλπυρiδιν-2-οnhς χρησιμες για τη θεραπεια καρκινου και διαβητη
EA201490357A1 (ru) Индазолы
EA202091477A1 (ru) Замещенные соединения простых индольных эфиров
CY1123285T1 (el) Ενωσεις 6-αρυλ-4-(μορφολιν-4-υλ)-1η-πυριδιν-2-ονης χρησιμες για τη θεραπεια καρκινου και διαβητη
CL2021002309A1 (es) Compuestos útiles en la terapia del vih
MX392270B (es) Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
UY36713A (es) Triazoles para el tratamiento de enfermedades desmielinizantes
CY1125082T1 (el) Υποκατεστημενα τριαζολια και μεθοδοι που σχετιζονται με αυτα
CY1121898T1 (el) Ενωσεις αμιδιου ως αγωνιστες tου υποδοχεα 5-ht4
CY1121650T1 (el) Αναστολεις συνθασης αλδοστερονης
CY1122077T1 (el) Νεα δακτυλιωμενα φαινοξυακεταμιδια
CY1123864T1 (el) Νεα παραγωγα αμινο-ιμιδαζοπυριδινης σαν αναστολεις κινασης janus και φαρμακευτικες χρησεις
BR112018000925A2 (pt) composto heterocíclico contendo nitrogênio